Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience

被引:31
作者
Cavaleri, Marco [1 ]
Manolis, Efthymios [2 ]
机构
[1] European Med Agcy, Human Med Evaluat Div, Antiinfect & Vaccines, London, England
[2] European Med Agcy, Human Med Res & Dev Support Div Sci Advice, London, England
关键词
tuberculosis; PK/PD; in vitro models; EMA; qualification;
D O I
10.1093/cid/civ484
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The in vitro hollow fiber system model has been qualified by the European Medicines Agency as a methodology for use in support of selection and development of antituberculosis regimens. More data are expected to be generated in the future to further characterize its value.
引用
收藏
页码:S1 / S4
页数:4
相关论文
共 12 条
  • [1] 2 COMPARTMENT KINETIC-MODEL WITH MULTIPLE ARTIFICIAL CAPILLARY UNITS
    BLASER, J
    STONE, BB
    ZINNER, SH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 : 131 - 137
  • [2] Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
    Drusano, George L.
    Neely, Michael
    Van Guilder, Michael
    Schumitzky, Alan
    Brown, David
    Fikes, Steven
    Peloquin, Charles
    Louie, Arnold
    [J]. PLOS ONE, 2014, 9 (07):
  • [3] European Medicines Agency, 2015, ROAD MAP
  • [4] European Medicines Agency, DRAFT CONCEPT PAPER
  • [5] European Medicines Agency, FIN QUAL OP
  • [6] European Medicines Agency, CONC PAP REV ADD NOT
  • [7] European Medicines Agency, NOV METH WEBP
  • [8] Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
    Gumbo, Tawanda
    Pasipanodya, Jotam G.
    Romero, Klaus
    Hanna, Debra
    Nuermberger, Eric
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 : S25 - S31
  • [9] Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
    Gumbo, Tawanda
    Pasipanodya, Jotam G.
    Nuermberger, Eric
    Romero, Klaus
    Hanna, Debra
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 : S18 - S24
  • [10] Manolis E, 2015, METHODS MOL BIOL, V1243, P255, DOI 10.1007/978-1-4939-1872-0_15